Zhongyuan H. Wang

Guiyang, 550002, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Discovery of a highly selective FLT3-ITD inhibitor with potent antileukemic activity based on 4-(2-fluorophenoxy)pyridine scaffold.

Discovery of a highly selective FLT3-ITD inhibitor with potent antileukemic activity based on 4-(2-fluorophenoxy)pyridine scaffold.

Journal: European journal of medicinal chemistry
Published: July 28, 2026

Identification of 2,4-disubstitued pyridine derivatives as potent FMS-like tyrosine receptor kinase 3 (FLT3) inhibitors.

Identification of 2,4-disubstitued pyridine derivatives as potent FMS-like tyrosine receptor kinase 3 (FLT3) inhibitors.

Journal: Bioorganic chemistry
Published: September 28, 2025

Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)pyridine derivatives as novel FLT3-ITD inhibitors.

Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)pyridine derivatives as novel FLT3-ITD inhibitors.

Journal: European journal of medicinal chemistry
Published: February 11, 2025

Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials.

Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials.

Journal: Archives of osteoporosis
Published: November 20, 2024

Discovery of pyridine-based derivatives as FLT3 inhibitors for the treatment of acute myeloid leukemia.

Discovery of pyridine-based derivatives as FLT3 inhibitors for the treatment of acute myeloid leukemia.

Journal: European journal of medicinal chemistry
Published: October 08, 2024

Identification of novel PD-1/PD-L1 small molecule inhibitors: virtual screening, synthesis and in vitro characterisation.

Identification of novel PD-1/PD-L1 small molecule inhibitors: virtual screening, synthesis and in vitro characterisation.

Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 18, 2024

Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials.

Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials.

Journal: Archives of osteoporosis
Published: May 29, 2024

Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer.

Discovery of LAH-1 as potent c-Met inhibitor for the treatment of non-small cell lung cancer.

Journal: Journal of enzyme inhibition and medicinal chemistry
Published: December 11, 2023

Design, synthesis and evaluation of 2, 6, 8-substituted Imidazopyridine derivatives as potent PI3Kα inhibitors.

Design, synthesis and evaluation of 2, 6, 8-substituted Imidazopyridine derivatives as potent PI3Kα inhibitors.

Journal: Journal of enzyme inhibition and medicinal chemistry
Published: January 18, 2023

Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors.

Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors.

Journal: Journal of enzyme inhibition and medicinal chemistry
Published: November 09, 2021

Perioperative factors affecting the length of hospital stay after cesarean section of pregnant women with heart disease

Perioperative factors affecting the length of hospital stay after cesarean section of pregnant women with heart disease

Journal: Zhonghua fu chan ke za zhi
Published: June 22, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026